Cite
Rouby JJ, Monsel A, Leone M, et al. The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation. Anaesth Crit Care Pain Med. 2020;39(2):179-183doi: 10.1016/j.accpm.2020.03.007.
Rouby, J. J., Monsel, A., Leone, M., Mimoz, O., Laterre, P. F., & Pugin, J. (2020). The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation. Anaesthesia, critical care & pain medicine, 39(2), 179-183. https://doi.org/10.1016/j.accpm.2020.03.007
Rouby, Jean-Jacques, et al. "The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation." Anaesthesia, critical care & pain medicine vol. 39,2 (2020): 179-183. doi: https://doi.org/10.1016/j.accpm.2020.03.007
Rouby JJ, Monsel A, Leone M, Mimoz O, Laterre PF, Pugin J. The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation. Anaesth Crit Care Pain Med. 2020 Apr;39(2):179-183. doi: 10.1016/j.accpm.2020.03.007. Epub 2020 Mar 07. PMID: 32156643.
Copy
Download .nbib